Track topics on Twitter Track topics that are important to you
Presidential candidates, lawmakers, policymakers, and the public should put pressure on regulators like the FTC to apply more scrutiny to multibillion-dollar mergers in the pharma industry.
Original Article: Opinion: Pharmaceutical mergers and megamergers stifle innovationNEXT ARTICLE
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.